National Cooperative Group Trials of “High-Risk” Patients With Lung Cancer: Are They Truly “High-Risk”?

There are no important differences in early postsurgical outcomes between lung cancer patients characterized as “high-risk” and “normal-risk” by ACOSOG trial enrollment criteria, despite a significant proportion of “high-risk” patients undergoing lobectomy.